Market Access/ News/ News Roche grabs FDA okay for would-be blockbuster eye drug faricimab Phil Taylor Bayer, DME, Eylea, ophthalmology, Regeneron, regulatory approval, Roche, Susvimo, Vabysmo, wet AMD 0 Comment The FDA has approved Roche’s much-anticipated faricimab for two major causes of blindness, setting up a market clash Share X Roche grabs FDA okay for would-be blockbuster eye drug faricimab https://pharmaphorum.com/news/roche-grabs-fda-okay-for-would-be-blockbuster-eye-drug-faricimab/